Damora Therapeutics, Inc. (DMRA) cash on hand

Cash · fiscal 2025
$257.62M

Damora Therapeutics, Inc. (DMRA) held cash of $257.62M at the end of fiscal 2025 (December 31, 2025). That is 1717.5% higher than the $14.18M of fiscal 2024. Figures as of 17 Nov 2026, 23:47 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Cash, fiscal 2025
$257.62M
Change on fiscal 2024
+1717.5%
Highest on record
$257.62Mfiscal 2025
Lowest on record
$14.18Mfiscal 2024
Fiscal years on record
42022–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Damora Therapeutics, Inc. cash on hand, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $257.62M in fiscal 2025 and the lowest $14.18M in fiscal 2024.

History · 4 fiscal years

Cash by fiscal year

Damora Therapeutics, Inc. cash on hand, year by year

Damora Therapeutics, Inc. (DMRA) cash on hand by fiscal year
Fiscal yearCashChangeYear ended
2025$257.62M 1,717.5% up
2024$14.18M 57.2% down
2023$33.15M 45.0% down
2022$60.22M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Cash is the cash, cash equivalents and short-term investments on the balance sheet at the fiscal year-end, shown for the fiscal years the market data feed covers because the older SEC record counts cash and equivalents alone.

How to read it

Cash is the cushion that pays for bad years, buybacks and acquisitions; compare it with total debt to see whether the company is a net borrower.

More on DMRA

Damora Therapeutics, Inc., figure by figure

Damora Therapeutics, Inc. (DMRA) overview: price, valuation and scorecard

Damora Therapeutics, Inc. cash on hand: questions and answers

How much cash does Damora Therapeutics, Inc. have?

Damora Therapeutics, Inc. (DMRA) held cash of $257.62M at the end of fiscal 2025 (December 31, 2025). That is 1717.5% higher than the $14.18M of fiscal 2024.

What are the highest and lowest cash figures on record for Damora Therapeutics, Inc.?

Across the 4 fiscal years on record (2022–2025), the highest was $257.62M in fiscal 2025 and the lowest $14.18M in fiscal 2024.

How is Damora Therapeutics, Inc.'s cash calculated?

Cash is the cash, cash equivalents and short-term investments on the balance sheet at the fiscal year-end, shown for the fiscal years the market data feed covers because the older SEC record counts cash and equivalents alone.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Damora Therapeutics, Inc. (DMRA) cash on hand”, data as of 17 November 2026. https://funkfolio.com/stock/DMRA/cash

Underlying data: the company's filings with the SEC and Yahoo Finance.